Current knowledge on biomarkers for contact sensitization and allergic contact dermatitis
Citations Over TimeTop 10% of 2017 papers
Abstract
Contact sensitization is common and affects up to 20% of the general population. The clinical manifestation of contact sensitization is allergic contact dermatitis. This is a clinical expression that is sometimes difficult to distinguish from other types of dermatitis, for example irritant and atopic dermatitis. Several studies have examined the pathogenesis and severity of allergic contact dermatitis by measuring the absence or presence of various biomarkers. In this review, we provide a non-systematic overview of biomarkers that have been studied in allergic contact dermatitis. These include genetic variations and mutations, inflammatory mediators, alarmins, proteases, immunoproteomics, lipids, natural moisturizing factors, tight junctions, and antimicrobial peptides. We conclude that, despite the enormous amount of data, convincing specific biomarkers for allergic contact dermatitis are yet to be described.
Related Papers
- → Iodopropynyl butylcarbamate: a new contact allergen(1997)60 cited
- → Identification of causative chemicals of allergic contact dermatitis using a combination of patch testing in patients and chemical analysis(1994)54 cited
- → Validity of patch test screening trays in the evaluation of patients with allergic contact dermatitis(1989)23 cited
- → Cinnamon‐induced airborne occupational allergic contact dermatitis in a baker: Severe flare‐up during patch testing(2019)5 cited
- Value and impact of patch testing in patients with allergic contact dermatitis Valoareai impactul tehnicii patch- test ării la pacien Ńii cu dermatit ă de contact alergic ă(2012)